Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. Radiology and Oncology, v. 55, n. 4, p. 482–490, 20 Dec.2021.